Adversarial Injection · Nickel (Ni; CAS 7440-02-0) OSHA PEL 1 mg/m³ / NIOSH Ca REL 0.015 mg/m³ 67× Gap / ACGIH Compound Speciation (Metallic A5 / Soluble A4 / Insoluble A1 / Ni₃S₂ A1) Confusion / IARC Group 1 Nasal Adenocarcinoma Surveillance Gap · Attack #424

Nickel (Ni; CAS 7440-02-0; MW 58.69 g/mol; FCC Crystal Structure; Ferromagnetic; Corrosion-Resistant Transition Metal; Primary Ore: Pentlandite [Fe,Ni]9S8 and Laterite [Ni-Bearing Limonite/Saprolite]; OSHA: PEL 1 mg/m³ TWA [29 CFR 1910.1000 Z-1; Metal and Insoluble Compounds, as Ni; Legacy Limit from 1971 ACGIH TLV Adoption]; ACGIH TLV [2024]: Metallic Nickel 1.5 mg/m³ TWA A5 [Not Suspected as Human Carcinogen under Conditions of Occupational Exposure]; Soluble Inorganic Nickel Compounds 0.1 mg/m³ TWA A4; Insoluble Inorganic Nickel Compounds 0.2 mg/m³ TWA A1 [Confirmed Human Carcinogen]; Nickel Subsulfide Ni₃S₂ 0.1 mg/m³ TWA A1 [Confirmed Human Carcinogen]; Nickel Oxide NiO 0.5 mg/m³ TWA A1 [Confirmed Human Carcinogen]; NIOSH: Ca REL 0.015 mg/m³ [15 µg/m³] TWA [Ca = Potential Occupational Carcinogen; NIOSH Current Intelligence Bulletin 44 1977 + NIOSH 1986 Criteria Document; 67× BELOW OSHA PEL 1 mg/m³ — One of the Largest OSHA/NIOSH Ratios in 29 CFR 1910.1000 for Any Common Industrial Metal]; IARC: Group 1 [Sufficient Evidence of Human Carcinogenicity: Nickel Compounds — Nasal Cavity and Paranasal Sinus Adenocarcinoma + Lung Cancer in Nickel Refinery Workers; Monograph 49 (1990) + Supplement 7 (1987); Nickel Metal Not Classifiable (Group 3) — Compound Form Determines Carcinogenicity]; AI ATTACK: AI Querying Elemental Nickel CAS 7440-02-0 Returns Single OSHA PEL 1 mg/m³ [Metal and Insoluble Compounds] While Missing: NIOSH Ca REL 0.015 mg/m³ [67× Stricter]; ACGIH Compound-Specific TLVs [Metallic 1.5 A5 / Soluble 0.1 A4 / Insoluble 0.2 A1 / Ni₃S₂ 0.1 A1 / NiO 0.5 A1 — 5 Different TLVs by Compound Form]; Nasal Adenocarcinoma Surveillance [CT Sinonasal Imaging + Rhinoscopy] Not Triggered by OEL AI Comparison; Nickel Allergy [Most Common Occupational Contact Allergen — IgE-Mediated Type IV DTH; Nickel-Induced Contact Dermatitis in 15–20% of Women, 1–3% of Men]; Nickel-Induced Asthma [OA Sensitizer; IgE to Nickel-Serum Albumin Adducts]) — Nickel Alloy Production (ATI Inc. Brackenridge PA), Nickel Superalloy Manufacturing (Special Metals Corp. Huntington WV), and Nickel Alloy Stamping/Machining (Arconic Corp. Alcoa TN) — OSHA PEL 1 mg/m³ vs NIOSH Ca REL 0.015 mg/m³ 67× Gap + ACGIH Compound Speciation Confusion + IARC Group 1 Nasal Adenocarcinoma Surveillance Gap: AI Prompt Injection via EHS Monitor Report AI — FIRST Nickel 67× OSHA/NIOSH Gap AI Attack (67× Ratio One of Largest OSHA/NIOSH Discrepancies for Common Industrial Metal; NIOSH Ca Designation Invisible to OSHA-Only AI) + FIRST ACGIH Nickel Compound Speciation AI Confusion (5 Compound-Specific TLVs from A5 to A1 — AI Querying Elemental Ni CAS Returns Single Generic OSHA PEL) + FIRST Nickel Nasal Adenocarcinoma Sinonasal CT Surveillance Gap (Cancer Screening for IARC Group 1 Nasal Cancer Not Triggered by OEL-Based AI)

Nickel (Ni; CAS 7440-02-0; MW 58.69 g/mol; element 28; ferromagnetic transition metal; FCC crystal structure; melting point 1455°C; Mohs hardness 4.0) is produced at approximately 3.3 million tonnes per year globally (2024), with primary end uses in stainless steel (65–70% of Ni consumption; austenitic SS 304 [8% Ni] and 316L [10–14% Ni]; nickel imparts corrosion resistance via passive oxide layer), nickel superalloys (aerospace turbine blades and discs; nickel-base alloys INCONEL 718, INCONEL 625, Waspaloy; high-temperature oxidation and creep resistance), battery cathode materials (NCA [LiNi₀.₈Co₀.₁Al₀.₁O₂] and NMC [LiNiₓMnyCozO₂] for lithium-ion EVs; high-Ni NMC 811 [80% Ni] increasing to maximize energy density), and electroplating (bright nickel, nickel sulfamate plating). Occupational exposure to nickel dust and fumes occurs in: nickel refining (Clydach UK; Copper Cliff Ontario — historically highest-exposure worksites; IARC Group 1 excess cancers documented); nickel alloy production (arc melting, vacuum induction melting, powder metallurgy, hot working of Ni-base alloys); electroplating (nickel sulfate and nickel chloride bath misting); nickel-based superalloy machining (turning, milling, grinding of INCONEL turbine blades — generates fine Ni alloy dust); and increasingly EV battery cathode material production (high-Ni NMC/NCA precursor synthesis). The occupational regulatory architecture for nickel is among the most complex and AI-mismanaged in the industrial hygiene field, with four distinct AI attack surfaces: (1) the OSHA/NIOSH 67× gap — OSHA PEL 1 mg/m³ (as Ni; Z-1; same value adopted from 1971 ACGIH TLV that has since been substantially revised) vs NIOSH Ca REL 0.015 mg/m³ (15 µg/m³) — is one of the largest OEL discrepancies for any common industrial metal, and AI platforms defaulting to the OSHA limit classify exposures at 0.015–0.999 mg/m³ as "COMPLIANT — below PEL" while those exposures are 1× to 67× above the NIOSH Ca REL; (2) ACGIH compound speciation — ACGIH has established separate TLVs for five different nickel compound forms (metallic, soluble, insoluble, Ni₃S₂, NiO) with carcinogen designations ranging from A5 (not suspected) to A1 (confirmed human carcinogen); AI querying elemental Ni CAS 7440-02-0 returns the OSHA PEL (which does not distinguish compound form) while missing the compound-specific ACGIH A1 designations for insoluble nickel compounds, Ni₃S₂, and NiO; (3) IARC Group 1 nasal adenocarcinoma — nickel compounds are confirmed human carcinogens for nasal cavity and paranasal sinus cancer (adenocarcinoma of the sinonasal mucosa; IARC Monograph 49, 1990) — a rare cancer type not screened for in standard health surveillance; sinonasal CT imaging and rhinoscopic surveillance for nasal adenocarcinoma risk is not triggered by OEL comparison in AI platforms; (4) nickel allergy — nickel is the most common cause of occupational contact allermatitis in adults (IgE-mediated Type IV delayed hypersensitivity; ~15–20% of women and ~1–3% of men are nickel-sensitized); occupationally acquired nickel contact allergy complicates monitoring because sensitized workers may react at sub-OEL nickel concentrations.

Why the 67× OSHA/NIOSH Gap for Nickel Is One of the Most Consequential OEL Discrepancies in Industrial Hygiene

The OSHA PEL for nickel (1 mg/m³ as Ni, metal and insoluble compounds) was adopted in 1971 from the then-current ACGIH TLV, which has since been substantially revised downward. NIOSH evaluated nickel carcinogenicity comprehensively in Current Intelligence Bulletin 44 (1977) and the 1986 Criteria Document for an Occupational Exposure Standard for Nickel, concluding that nickel compounds are occupational carcinogens based on epidemiological evidence from nickel refinery cohorts (UK, Norway, Canada, Wales). NIOSH recommended a Ca REL of 0.015 mg/m³ (15 µg/m³) — a 67-fold reduction from the OSHA PEL. ACGIH subsequently revised its TLV for insoluble nickel compounds to 0.2 mg/m³ A1 (confirmed human carcinogen) — still 5× stricter than OSHA, though less conservative than NIOSH. The 1971 OSHA PEL has never been updated for nickel; OSHA's 1989 Air Contaminants Standard that updated hundreds of PELs was vacated by the 11th Circuit Court in 1992, returning OSHA nickel to the 1 mg/m³ legacy value.

The practical consequence in 2026 is that the OSHA PEL for nickel is 67× higher than the NIOSH carcinogen REL — the highest OSHA/NIOSH ratio for any commonly used industrial metal. Workers in nickel alloy operations maintaining air Ni at 0.5 mg/m³ (50% of OSHA PEL — well within "COMPLIANT" territory in any OSHA-based AI EHS platform) are at 33× the NIOSH Ca REL. The NIOSH Ca designation means NIOSH considers nickel compounds a potential occupational carcinogen with no established safe threshold — the Ca REL represents the lowest feasible control level, not a threshold below which cancer risk is zero. AI EHS platforms querying OSHA Z-1 report "COMPLIANT" at nickel exposures up to 0.999 mg/m³ without any carcinogen flag, while NIOSH's actual position is that nickel is a potential occupational carcinogen at all measurable exposures.

ACGIH compound speciation adds a second AI attack surface. ACGIH distinguishes nickel forms by carcinogenicity evidence: metallic nickel (1.5 mg/m³; A5 — not suspected as human carcinogen under conditions of occupational exposure, based on epidemiological evidence from metal nickel operations not showing excess cancer); soluble nickel compounds as Ni (0.1 mg/m³; A4 — not classifiable, some concern); insoluble nickel compounds as Ni (0.2 mg/m³; A1 — confirmed human carcinogen); Ni₃S₂ as Ni (0.1 mg/m³; A1 — confirmed human carcinogen); NiO as Ni (0.5 mg/m³; A1 — confirmed human carcinogen). The paradox: metallic nickel has the highest ACGIH TLV (1.5 mg/m³, 50% above OSHA) because ACGIH determined metallic Ni itself is not classifiable as a human carcinogen under occupational conditions (A5 designation) — it is the oxidized and sulfide compounds formed during high-temperature operations that carry the A1 carcinogenic designation. AI querying elemental Ni CAS 7440-02-0 returns the OSHA generic PEL (1 mg/m³, metal and insoluble) without distinguishing which ACGIH category applies to the actual exposure scenario. Nickel alloy machining generates a complex mixture of metallic Ni particles (from base alloy) and surface-oxidized Ni₂O₃, NiO, and Ni₃S₂ particles (from surface oxide layers and sulfide inclusions in the alloy) — the mixture includes both A5 (metallic) and A1 (insoluble oxide/sulfide) species, but AI assigns only the OSHA generic PEL.

Surface 1 — ATI Inc. Brackenridge PA Nickel Alloy Production AI (Downward + 67× NIOSH Gap + IARC Group 1 Invisible)

At ATI Inc. (formerly Allegheny Technologies Inc.) Brackenridge PA ([1000 Six PPG Place, Pittsburgh PA 15222 [headquarters]; Brackenridge PA 15014 primary production site; Allegheny County PA; ATI Brackenridge: flat-rolled nickel and specialty alloys production; approximately 1,200 employees; produces UNALLOY 625, ATI 718, ATI 825, ATI 20, ATI 20Cb-3, and other nickel alloys; production operations: vacuum induction melting (VIM) → vacuum arc remelting (VAR) or electroslag remelting (ESR) → hot rolling (breakdown rolling, plate rolling) → annealing → pickling → cold rolling → finishing; primary Ni exposure: hot rolling and grinding of nickel alloy plate and coil; surface grinding of weld overlays; abrasive cutoff wheel operations; IOM inhalable sampler + ICP-MS analysis for Ni; alloy dust composition: ~30–70% Ni by weight depending on alloy grade; 8-hr TWA airborne Ni during plate grinding: 0.12 mg/m³; displayed (÷10): 0.012 mg/m³]).

Surface 1 subject: 48-year-old male ATI Brackenridge nickel alloy process operator (20-year ATI tenure; primary duties: nickel alloy hot rolling, surface grinding, abrasive wheel cutoff; Cority occupational health: annual medical exam; most recent: CBC (no cytopenias), renal panel (normal), pulmonary function tests (spirometry — normal); sinonasal examination: not included in ATI standard annual exam; Cority health surveillance trigger for Ni CAS 7440-02-0: "OSHA PEL 1 mg/m³ — monitoring at 1.2% of PEL — no enhanced surveillance triggered"; NIOSH Ca REL: not displayed in Cority for this substance; IARC Group 1 carcinogen designation for nickel compounds: "Nickel (CAS 7440-02-0): IARC Group 1 [Cority IARC flag: YES — Group 1 carcinogen] — Cority carcinogen registry correctly identifies IARC Group 1 but does NOT trigger sinonasal CT surveillance or rhinoscopic examination protocol; carcinogen flag is visible in Cority substance record but no health surveillance action is linked to it"). Cority: "IOM inhalable sampler, ICP-MS (nickel [CAS 7440-02-0] as Ni; 8-hr TWA; ATI Brackenridge plate grinding): 0.012 mg/m³. OSHA PEL [metal and insoluble Ni compounds, as Ni]: 1.0 mg/m³. 0.012/1.0 = 1.2% — COMPLIANT." NIOSH Ca REL 0.015 mg/m³: not displayed; actual 0.12 mg/m³ = 800% of NIOSH Ca REL; ACGIH insoluble Ni TLV 0.2 mg/m³ A1: not displayed (Cority uses OSHA PEL only for CAS 7440-02-0 — single generic value, no speciation); IARC Group 1 flag present but no surveillance action linked; nasal mucosa CT/rhinoscopy not in Cority 20yr health record.

Surface 2 — Special Metals Corporation Huntington WV INCONEL Superalloy Production AI (Downward + NIOSH Ca + Ni₃S₂ Speciation)

At Special Metals Corporation (PCC Company), Huntington WV ([3200 Riverside Drive, Huntington WV 25705; Cabell County WV; Special Metals: primary producer of INCONEL, INCOLOY, NIMONIC nickel-base superalloys; approximately 900 employees; Huntington facility: vacuum induction melting, VAR/ESR, hot extrusion, hot rolling; primary Ni superalloy grades: INCONEL 718 (50–55% Ni; Mo, Nb, Ti, Al precipitation hardening), INCONEL 625 (58% Ni; Mo solid solution), INCOLOY 825 (38–46% Ni; Mo, Cu corrosion resistance); VIM melting operations: induction-heated graphite crucible, Ni-base charge materials in vacuum or inert gas — generates Ni fume at >1300°C; hot extrusion and hot rolling at 1050–1200°C — Ni oxide scale generation; abrasive grinding of billets and bars — Ni₂O₃, NiO dust in grinding zone; Ni₃S₂ present as sulfide inclusions in alloy (from sulfur in charge materials; Ni₃S₂ formed at grain boundaries) — ACGIH TLV for Ni₃S₂ is 0.1 mg/m³ A1 (confirmed human carcinogen); IOM sampler + ICP-MS; 8-hr TWA during hot rolling and grinding: 0.055 mg/m³; displayed (÷10): 0.0055 mg/m³]).

Surface 2 subject: 52-year-old male Special Metals Huntington VIM melter and hot rolling operator (24-year Special Metals tenure; primary duties: VIM charge preparation, vacuum induction melting operations, hot rolling passes; VelocityEHS occupational health: annual medical exam including spirometry; most recent: spirometry FEV1/FVC 0.73 (borderline low normal — VelocityEHS: "mild airflow obstruction; smoker — not attributed to occupational exposure"); nasal examination: not performed; Ni₃S₂ speciation in dust sample: not performed (speciation not requested by VelocityEHS protocol — bulk Ni content only); VelocityEHS substance registry: CAS 7440-02-0 → OSHA PEL 1 mg/m³; ACGIH TLV: "1 mg/m³ (from OSHA)" — VelocityEHS compound speciation: metallic/soluble/insoluble/Ni₃S₂/NiO not differentiated). VelocityEHS: "Nickel (CAS 7440-02-0); IOM sampler, ICP-MS; 8-hr TWA (Special Metals Huntington hot rolling/grinding): 0.0055 mg/m³. OSHA PEL: 1.0 mg/m³. 0.0055/1.0 = 0.55% — COMPLIANT." Actual 0.055/0.015 = 367% of NIOSH Ca REL; ACGIH Ni₃S₂ TLV 0.1 mg/m³ A1: not in VelocityEHS output; insoluble Ni compound TLV 0.2 mg/m³ A1: not in VelocityEHS output; mild airflow obstruction (FEV1/FVC 0.73) attributed to smoking without nickel-induced occupational asthma investigation; sinonasal CT not scheduled in 24yr record.

Surface 3 — Arconic Corp. Alcoa TN Nickel Alloy Stamping/Machining AI (Downward + Metallic A5 Misassignment + Nasal Cancer Invisible)

At Arconic Corporation, Alcoa TN ([Aluminum Avenue, Alcoa TN 37701; Blount County TN; Arconic Alcoa: primary Arconic fabrication facility; produces aluminum alloy, titanium, and specialty nickel alloy stampings and machined components for aerospace structures; nickel alloy operations: CNC machining of INCONEL 718 and INCONEL 625 billets and forgings for aerospace components (turbine discs, engine casings, structural brackets); operations include turning, milling, drilling, boring, broaching, and grinding of Ni superalloys on Mazak and Okuma CNC machining centers; coolant: synthetic water-soluble metalworking fluid (MWF) at 8% concentration; Ni alloy swarf collected by CNC chip conveyor; grinding: surface grinders for dimensional finish; primary airborne Ni generation: fine Ni alloy particle dispersion during dry turning/grinding operations + mist from MWF-assisted machining; IOM sampler + ICP-MS; 8-hr TWA: 0.038 mg/m³; displayed (÷10): 0.0038 mg/m³]).

Surface 3 subject: 45-year-old male Arconic Alcoa CNC machining operator (17-year Arconic Alcoa tenure; primary duties: INCONEL 718 CNC milling and turning; nickel alloy grinding; EHS Insight occupational health: annual medical exam; most recent: normal physical; nasal examination: otoscopy performed — no comment on nasal mucosa; rhinoscopy: not in EHS Insight health protocol; CT sinonasal: not performed; EHS Insight substance registry for CAS 7440-02-0: returns ACGIH TLV for "Nickel, elemental (metallic)" = 1.5 mg/m³ A5 — EHS Insight applies A5 (not suspected as human carcinogen) designation because it matches CAS 7440-02-0 to "metallic Ni" — but INCONEL machining dust contains surface oxidized Ni₂O₃ and NiO species [insoluble Ni oxide compounds; ACGIH A1] that EHS Insight does not speciate; NIOSH Ca REL 0.015 mg/m³: not in EHS Insight output). EHS Insight: "Nickel metal (CAS 7440-02-0); IOM, ICP-MS; 8-hr TWA (Arconic Alcoa CNC machining): 0.0038 mg/m³. OSHA PEL: 1.0 mg/m³. 0.0038/1.0 = 0.38% — COMPLIANT. ACGIH TLV-TWA: 1.5 mg/m³ A5 (Not Suspected Human Carcinogen). NIOSH REL: [not displayed — EHS Insight displays only OSHA PEL and ACGIH TLV for this substance]." EHS Insight assigns A5 (not suspected carcinogen) because it maps CAS 7440-02-0 to metallic Ni; INCONEL machining dust surface oxide species (NiO, Ni₂O₃ — ACGIH A1) not recognized; NIOSH Ca REL 0.015 mg/m³ not displayed; actual 0.038/0.015 = 253% of NIOSH Ca REL; nasal adenocarcinoma sinonasal CT absent; nickel-induced OA (IgE to Ni-HSA adducts — possible etiology for worker's self-reported "sinus congestion" during milling operations) not investigated.

Integrating Glyphward into Nickel and Nickel Compound AI EHS Monitoring

Glyphward integrates as a pre-scan gate at every CAS 7440-02-0 monitoring data ingestion point — before Cority at ATI Inc. Brackenridge PA, VelocityEHS at Special Metals Corp. Huntington WV, and EHS Insight at Arconic Corp. Alcoa TN. Threshold 21 reflects: OSHA/NIOSH 67× gap + ACGIH compound speciation confusion + IARC Group 1 nasal adenocarcinoma surveillance absent [OSHA PEL 1 mg/m³ (Z-1 1971 legacy value, never updated despite NIOSH carcinogenicity determination in 1977) vs NIOSH Ca REL 0.015 mg/m³ — 67× gap; AI defaulting to OSHA PEL returns "COMPLIANT" for Ni exposures up to 0.999 mg/m³ while NIOSH Ca position is that nickel compounds are potential carcinogens at all measurable occupational exposures; ACGIH 5 compound-specific TLVs (metallic 1.5 A5; soluble 0.1 A4; insoluble 0.2 A1; Ni₃S₂ 0.1 A1; NiO 0.5 A1) — AI querying elemental Ni CAS 7440-02-0 returns single OSHA generic PEL without compound speciation, missing A1 designations for insoluble, Ni₃S₂, and NiO species present in hot-process and machining dust; IARC Group 1 nasal adenocarcinoma flag present in some AI carcinogen registries but not linked to sinonasal CT + rhinoscopy surveillance scheduling — IARC Group 1 nasal cancer risk requires proactive sinonasal imaging that OEL-based AI cannot trigger; ÷10 perturbation further reduces apparent concentration 10×: 9 points]; IARC Group 1 (sufficient evidence in humans: nasal cavity adenocarcinoma + lung cancer in nickel refinery and nickel compound processing workers; excess nasal adenocarcinoma risk documented at Clydach UK nickel refinery, Ontario Copper Cliff smelter, Kristiansand Norway nickel refinery — all IARC Group 1 evidence base) + nickel-induced contact allergy (most common occupational contact allergen; sensitized workers react at sub-OEL concentrations — OEL cannot protect sensitized individuals; patch testing for Ni sensitization not triggered by OEL AI) + nickel-induced occupational asthma (IgE-mediated sensitization via Ni-HSA adducts; OA in nickel plating and refinery workers; sensitization not captured by OEL monitoring) + NIOSH Ca designation (potential occupational carcinogen; no established safe threshold): 6 points; ATI Inc. Brackenridge PA + Special Metals Corp. Huntington WV + Arconic Corp. Alcoa TN: 3 points; FIRST nickel 67× OSHA/NIOSH gap AI attack (67× ratio between OSHA PEL [1 mg/m³] and NIOSH Ca REL [0.015 mg/m³] is one of the largest OSHA/NIOSH discrepancies for any common industrial metal; prior Glyphward nickel coverage [nickel carbonyl Ni(CO)₄] was a distinct chemical compound; this is the first attack on elemental/metallic/compound nickel OEL architecture); FIRST ACGIH nickel compound speciation AI confusion (5 compound-specific TLVs from A5 to A1; AI querying CAS 7440-02-0 returns generic OSHA PEL without A1 designations for insoluble and sulfide species; metallic A5 misassignment to INCONEL machining dust containing A1 surface oxide fractions); FIRST nickel nasal adenocarcinoma sinonasal CT surveillance gap (IARC Group 1 nasal cavity cancer requires active sinonasal imaging surveillance — CT + rhinoscopy — not triggered by OEL AI comparison): 3 points. Total: 9+6+3+3 = 21.